Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management

被引:84
作者
Gregson, Celia L. [1 ,2 ]
Hardcastle, Sarah A. [1 ]
Cooper, Cyrus [2 ]
Tobias, Jonathan H. [1 ]
机构
[1] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol BS10 5NB, Avon, England
[2] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
DXA; BMD; high bone mass; osteopetrosis; osteoarthritis; C-ASSOCIATED OSTEOSCLEROSIS; AUTOSOMAL-DOMINANT OSTEOPETROSIS; IDIOPATHIC SKELETAL HYPEROSTOSIS; ALBERS-SCHONBERG-DISEASE; ENERGY X-RAY; BUSCHKE-OLLENDORFF-SYNDROME; CAMURATI-ENGELMANN-DISEASE; LATENCY-ASSOCIATED PEPTIDE; DOMAIN-SPECIFIC MUTATIONS; CLCN7; GENE-MUTATIONS;
D O I
10.1093/rheumatology/ket007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A finding of high BMD on routine DXA scanning is not infrequent and most commonly reflects degenerative disease. However, BMD increases may also arise secondary to a range of underlying disorders affecting the skeleton. Although low BMD increases fracture risk, the converse may not hold for high BMD, since elevated BMD may occur in conditions where fracture risk is increased, unaffected or reduced. Here we outline a classification for the causes of raised BMD, based on identification of focal or generalized BMD changes, and discuss an approach to guide appropriate investigation by clinicians after careful interpretation of DXA scan findings within the context of the clinical history. We will also review the mild skeletal dysplasia associated with the currently unexplained high bone mass phenotype and discuss recent advances in osteoporosis therapies arising from improved understanding of rare inherited high BMD disorders.
引用
收藏
页码:968 / 985
页数:18
相关论文
共 200 条
[1]  
Adami S, 2006, J BONE MINER RES, V21, pS24
[2]  
Albers-Schonberg HE, 1903, MUNCHEN MED WOCHEN, V5, P365
[3]  
[Anonymous], 1998, Am J Med Genet, V79, P376
[4]  
Arden NK, 1999, ARTHRITIS RHEUM, V42, P1378, DOI 10.1002/1529-0131(199907)42:7<1378::AID-ANR11>3.0.CO
[5]  
2-I
[6]  
Arden NK, 1996, BRIT J RHEUMATOL, V35, P1299
[7]   A clinical and molecular overview of the human osteopetroses [J].
Balemans, W ;
Van Wesenbeeck, L ;
Van Hul, W .
CALCIFIED TISSUE INTERNATIONAL, 2005, 77 (05) :263-274
[8]   Localization of the gene for sclerosteosis to the van Buchem Disease-gene region on chromosome 17q12-q21 [J].
Balemans, W ;
Van Den Ende, J ;
Paes-Alves, AF ;
Dikkers, FG ;
Willems, PJ ;
Vanhoenacker, F ;
de Almeida-Melo, N ;
Alves, CF ;
Stratakis, CA ;
Hill, SC ;
Van Hul, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) :1661-1669
[9]   Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling [J].
Balemans, Wendy ;
Devogelaer, Jean-Pierre ;
Cleiren, Erna ;
Piters, Elke ;
Caussin, Emanuelle ;
Van Hul, Wim .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (05) :708-716
[10]   Systemic mastocytosis and bone involvement in a cohort of 75 patients [J].
Barete, S. ;
Assous, N. ;
de Gennes, C. ;
Grandpeix, C. ;
Feger, F. ;
Palmerini, F. ;
Dubreuil, P. ;
Arock, M. ;
Roux, C. ;
Launay, J. M. ;
Fraitag, S. ;
Canioni, D. ;
Billemont, B. ;
Suarez, F. ;
Lanternier, F. ;
Lortholary, O. ;
Hermine, O. ;
Frances, C. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) :1838-1841